Calcium Signaling: ANO8 assembles STIM1, Orai1, SERCA2, and PMCA at ER/PM junctions, enhancing SOCE and mediating Orai1 channel inactivation via SERCA2-dependent calcium sequestration .
ER/PM Tethering: ANO8 increases the size and number of ER/PM junctions, directly influencing STIM1-STIM1 and STIM1-Orai1 interactions .
IHC: Strong staining in mouse brain tissue, particularly in neuronal regions .
Specificity: Validated via protein arrays (e.g., 364 non-specific proteins tested for cross-reactivity) .
ANO8 antibodies have been instrumental in elucidating the protein’s role in cellular processes:
STIM1-Orai1 Interaction: ANO8 knockdown reduces STIM1-STIM1 clustering by 50% and SOCE by 70%, as shown via TIRF microscopy and Co-IP assays .
Channel Inactivation: ANO8 facilitates SERCA2-mediated calcium influx into the ER, modulating Orai1 inactivation even at low cytoplasmic calcium levels (0.2 nM) .
Cancer: ANO8 is upregulated in certain tumors, with potential roles in proliferation and apoptosis via CAMKII signaling .
Neurological Disorders: ANO8 expression in brain tissues suggests involvement in neuronal calcium homeostasis .
Antigen Retrieval: Optimal IHC results require TE buffer (pH 9.0) or citrate buffer (pH 6.0) .
Storage: Stable at -20°C in PBS with 0.02% sodium azide and 50% glycerol .
Mechanistic Studies: Further exploration of ANO8’s role in CAMKII signaling and disease pathways.
Therapeutic Targeting: Potential for ANO8 inhibitors in calcium-related pathologies.
ANO8 belongs to the anoctamin family and functions as a key tether in the formation of endoplasmic reticulum (ER) and plasma membrane (PM) junctions. It plays an essential role in STIM1-STIM1 interaction and STIM1-Orai1 interaction at ER/PM PI(4,5)P₂-rich compartments. ANO8 is significant because it assembles core calcium signaling proteins (Orai1, PMCA, STIM1, IP₃ receptors, and SERCA2) at the ER/PM junctions, thereby mediating Orai1 channel inactivation and controlling receptor-stimulated Ca²⁺ signaling and oscillations . Detecting and studying ANO8 is crucial for understanding fundamental calcium signaling mechanisms in cellular physiology.
Based on available research materials, ANO8 antibodies have been validated for multiple experimental applications:
| Application | Typical Dilution | Notes |
|---|---|---|
| Immunohistochemistry (IHC) | 1:250-1:1000 | Optimal with TE buffer pH 9.0 for antigen retrieval |
| Immunofluorescence (IF) | Varies by antibody | Used for subcellular localization studies |
| Western Blot (WB) | Varies by antibody | Detects ANO8 at ~136 kDa |
| Immunocytochemistry (ICC) | Varies by antibody | For cellular localization studies |
| ELISA | Varies by antibody | For quantitative detection |
The antibodies show reactivity with human, mouse, and rat samples, making them versatile tools for comparative studies across species .
For optimal ANO8 detection, a titration approach is recommended rather than relying solely on manufacturer-suggested dilutions. Begin with a dilution series (e.g., 1:100, 1:250, 1:500, 1:1000) in your specific system. For IHC applications, start with the recommended range of 1:250-1:1000 . Include appropriate positive controls (such as mouse brain tissue) and negative controls (omitting primary antibody or using tissue known to lack ANO8 expression).
Evaluate signal-to-noise ratio across different concentrations to determine the optimal dilution that provides specific staining with minimal background. This is particularly important for ANO8 detection because its expression levels can vary significantly between tissues and experimental conditions. Remember that optimal concentration may need adjustment based on:
Sample preparation method
Fixation protocol
Antigen retrieval technique (TE buffer pH 9.0 is suggested for ANO8 IHC, with citrate buffer pH 6.0 as an alternative)
Detection system sensitivity
When studying ANO8 as an ER/PM junction tether, sample preparation requires careful consideration to preserve these delicate membrane structures:
For immunofluorescence/confocal microscopy:
Fixation: 4% paraformaldehyde (10-15 minutes at room temperature) preserves membrane architecture while allowing antibody access.
Permeabilization: Use gentle detergents (0.1% Triton X-100 or 0.1% saponin) to avoid disrupting membrane junctions.
Blocking: 5% BSA or 10% serum from the secondary antibody host species (1 hour at room temperature).
Primary antibody: Apply ANO8 antibody at optimized dilution overnight at 4°C.
Secondary antibody: Fluorophore-conjugated antibody (1:500-1:1000) for 1-2 hours at room temperature.
For electron microscopy (EM) of ER/PM junctions containing ANO8:
EM has been successfully used to visualize ANO8-enriched junctions, showing that ANO8 increases both the number and size of ER/PM junctions . Standard EM fixation protocols with glutaraldehyde followed by osmium tetroxide provide good preservation of these structures.
For subcellular fractionation:
When biochemically isolating ER/PM junctions, use sucrose gradient ultracentrifugation methods optimized for membrane contact sites, followed by immunoblotting for ANO8 detection.
Total Internal Reflection Fluorescence (TIRF) microscopy is an ideal technique for studying ANO8 at ER/PM junctions due to its ability to visualize events near the plasma membrane with high resolution. Based on published methodologies:
Sample preparation:
Express fluorescently tagged constructs (ANO8-YFP, mCherry-STIM1, Orai1-CFP) in appropriate cell lines
For fixed samples, use minimal fixation (2% PFA for 10 minutes) to preserve fluorescent proteins
Mount samples in imaging chambers with glass bottoms of appropriate thickness for TIRF
TIRF setup optimization:
Adjust the incident angle to achieve an evanescent field depth of ~100-150 nm
Use multi-color TIRF to simultaneously visualize ANO8 with interaction partners
For dynamic studies, maintain cells at 37°C with appropriate buffers
Analysis strategies:
Research has shown that ANO8 forms puncta at the TIRF field that increase after store depletion, with N-terminally tagged mCherry-STIM1 clusters forming at ANO8 puncta but in a plane farther from the plasma membrane than ANO8 .
When designing co-immunoprecipitation (Co-IP) or FRET experiments to study ANO8 interactions with calcium signaling proteins, the following controls are essential:
For Co-IP studies:
Input control: Analyze 5-10% of pre-IP lysate to confirm protein expression
Negative controls:
IgG control: Use matched isotype control antibody to assess non-specific binding
Knockdown control: Include samples with ANO8 siRNA/shRNA to demonstrate specificity
Reciprocal IP: Perform reverse IP (e.g., IP with STIM1 antibody, blot for ANO8)
Stimulus controls: Compare resting cells vs. store-depleted conditions
For FRET experiments:
Donor-only control: Cells expressing only the donor fluorophore
Acceptor-only control: Cells expressing only the acceptor fluorophore
Negative interaction control: Non-interacting proteins with the same fluorophores
Positive control: Known interaction partners labeled with the same fluorophores
Published research demonstrates significant basal FRET between STIM1-CFP and ANO8-YFP that was enhanced by expression of HA-Orai1, while minimal basal FRET was observed between Orai1 and ANO8 even when co-expressed with STIM1 .
ANO8 knockdown significantly impairs the formation of STIM1 puncta and STIM1-Orai1 complexes at ER/PM junctions, with several complementary methods demonstrating this effect:
Functional impact:
70% reduction in Orai1 current without altering channel inward rectification
50% reduction in native store-operated Ca²⁺ influx
Detection methods:
Electrophysiology: Patch-clamp recordings show decreased current density in ANO8 knockdown cells
Calcium imaging: Reduced store-operated Ca²⁺ entry measured by fluorescent indicators
TIRF microscopy: Quantitative analysis of STIM1 and Orai1 puncta formation
Co-IP assays: Reduced native STIM1-Orai1 interaction following store depletion
Surface biotinylation: Decreased PM-localized Orai1 and STIM1 at junctions
These methods collectively demonstrate that ANO8 functions as a bona fide ER/PM tether that regulates the assembly and interaction of STIM1 and Orai1 at junctions, thereby controlling Orai1 activation by STIM1 and the duration of Ca²⁺ influx .
This question addresses a sophisticated aspect of ANO8 function that requires specialized experimental approaches to delineate:
To isolate effects on STIM1-STIM1 interaction:
FRET between STIM1 molecules: Measure STIM1-STIM1 FRET efficiency in the ER (away from PM) with and without ANO8
Co-IP of differently tagged STIM1 proteins: Assess STIM1-STIM1 interaction in cells with ANO8 expression or knockdown
BiFC (Bimolecular Fluorescence Complementation): Split fluorescent protein fragments attached to STIM1 molecules will fluoresce only upon STIM1-STIM1 interaction
To isolate effects on tethering function:
Constitutively active STIM1 mutants: Use pre-clustered STIM1 mutants (STIM1(D76A), STIM1-Kras, STIM1(ΔCTID)) whose clustering is independent of store depletion
Electron microscopy: Direct visualization and quantification of ER/PM junctions
Surface biotinylation assays: Measure PM-localized Orai1 and associated STIM1
These approaches collectively demonstrate that ANO8 has dual functions: enhancing STIM1-STIM1 interaction in the ER and increasing the formation of ER/PM junctions where STIM1-Orai1 complexes assemble.
Electrophysiological approaches:
Compare SCDI kinetics with 3mM EGTA (slower Ca²⁺ buffer) vs. 10mM BAPTA (faster Ca²⁺ buffer)
Measure inactivation in SARAF knockdown cells with and without ANO8 expression
Analyze current traces for distinctive kinetic components
Molecular manipulation experiments:
SARAF knockdown/knockout with ANO8 expression shows only partial reduction in SCDI
Compare effects of ANO8 on wild-type Orai1 vs. inactivation-resistant Orai1 mutants
Express ANO8 mutants lacking specific protein interaction domains
Proximity analysis techniques:
FRET measurements between ANO8, SARAF, STIM1, and Orai1
Co-IP experiments to detect molecular complexes under different conditions
Research has shown that ANO8 increases interaction of SARAF with STIM1 (enhancing SARAF-dependent SCDI) but also reveals a SARAF-independent form of Orai1 inactivation . This novel form involves ANO8 facilitating SERCA2-mediated Ca²⁺ influx into the ER, creating a distinct regulatory mechanism for calcium signaling.
Epitope masking occurs when protein-protein interactions obscure antibody binding sites. For ANO8, which forms complexes with multiple calcium signaling proteins (STIM1, Orai1, SERCA2, IP₃R), this presents a significant challenge:
Detection strategies to overcome masking:
Multiple antibody approach: Use antibodies targeting different epitopes of ANO8
Sample preparation modifications:
Test different detergents in lysis buffers (CHAPS vs. Triton X-100 vs. digitonin)
Try partial protein denaturation protocols that maintain epitope structure
Use cross-linking approaches to stabilize complexes before detection
Alternative detection methods:
Proximity ligation assay (PLA) to detect ANO8 in close proximity to partners
Mass spectrometry-based approaches for complex composition analysis
Expression of epitope-tagged ANO8 constructs with tags in different protein regions
Documentation and validation:
Always document experimental conditions where epitope masking might occur
Compare results across resting and stimulated conditions
Validate findings with orthogonal approaches (e.g., fluorescent protein fusion imaging)
When researchers encounter variable results with ANO8 antibodies across different cell types or experimental conditions, systematic troubleshooting is essential:
Source of variability and resolution strategies:
Expression level differences:
Quantify ANO8 expression by qPCR across systems
Use Western blot with recombinant protein standards for absolute quantification
Adjust antibody concentration based on expression level in each system
Post-translational modifications:
Isoform variation:
Methodology standardization:
Reconciliation of data:
Create a detailed comparison table documenting all variables across experimental systems including fixation, permeabilization, blocking, antibody concentration, and detection method. This systematic approach will identify the source of variability and guide protocol optimization.
ANO8 knockdown experiments have revealed its critical role in calcium signaling, but interpreting such data requires careful consideration of several factors:
Interpretation framework:
Direct vs. indirect effects:
ANO8 knockdown reduces STIM1-STIM1 and STIM1-Orai1 interaction
It decreases ER/PM junctions, Orai1 current, and Ca²⁺ influx
Consider whether observed phenotypes result from direct ANO8 loss or secondary effects
Compensatory mechanisms:
Other anoctamin family members may partially compensate
Prolonged knockdown may trigger different adaptations than acute depletion
Compare siRNA (acute) vs. shRNA/CRISPR (chronic) approaches
System-specific considerations:
Effects may vary between cell types with different calcium signaling machinery
Primary cells vs. cell lines may show distinct responses
Consider the relative importance of ANO8 vs. other tethers in your system
Analytical approaches:
Time-course analysis: Examine effects at different time points after knockdown
Dose-dependent studies: Use partial knockdown to reveal threshold effects
Rescue experiments: Re-express ANO8 or specific domains to identify critical regions
Combined knockdowns: Target ANO8 together with other tethers to assess redundancy
Interpretation of calcium signaling data:
Research shows that ANO8 knockdown reduces store-operated Ca²⁺ entry by approximately 50% and Orai1 current by 70% . This partial rather than complete inhibition suggests that other tethering mechanisms contribute to ER/PM junction formation and calcium signaling, even in the absence of ANO8.
Understanding ANO8's function across different physiological contexts represents a frontier in calcium signaling research:
Advanced methodological approaches:
Tissue-specific conditional knockout models:
Generate ANO8 floxed mice for tissue-specific deletion
Compare phenotypes across tissues with different calcium signaling requirements
Assess compensatory changes in other tethering proteins
Advanced imaging techniques:
Super-resolution microscopy (STORM/PALM) to visualize ANO8 nanoscale organization
Lattice light-sheet microscopy for 3D dynamics in living tissues
Correlative light and electron microscopy (CLEM) to link ANO8 location with ultrastructure
Physiological context exploration:
Examine ANO8 in specialized calcium signaling contexts (neurons, immune cells, etc.)
Study its role during development and aging
Investigate ANO8 function in disease models with altered calcium homeostasis
Current antibodies show reactivity with human, mouse, and rat samples , providing tools for comparative studies across species. The documented expression in mouse brain tissue suggests neuronal calcium signaling as a promising area for investigation.
ANO8 belongs to the anoctamin family, members of which can function as calcium-activated chloride channels, yet current research emphasizes its tethering function:
Experimental strategies to distinguish these roles:
Structure-function analysis:
Generate ANO8 mutants that preserve tethering but disrupt potential channel function
Use patch-clamp electrophysiology to directly assess channel activity
Compare ANO8 to established anoctamin channels (ANO1/2) in parallel assays
Ion flux measurements:
Use chloride-sensitive fluorescent indicators to detect potential ANO8-mediated flux
Perform ion substitution experiments to determine ion selectivity
Examine calcium dependence of any observed channel activity
Molecular-level approaches:
Compare ANO8 structure with known channel-forming anoctamins
Identify and mutate potential pore-forming regions
Assess oligomerization properties characteristic of ion channels
Current literature states that ANO8 "may act as a calcium-activated chloride channel" , suggesting this function remains hypothetical. In contrast, its tethering role in ER/PM junctions has been experimentally demonstrated . Resolving this dual functionality question would significantly advance our understanding of ANO8 biology.